Showing posts with label Building Wealth. Show all posts
Showing posts with label Building Wealth. Show all posts

Monday, May 25, 2020

May 18 - 22 Performance (IBio Inc., Microvision, Fuel Cell Energy, more)

Here are some metrics and notes for the fund's activity during May 18 - 22.


Security/ ProjectType Date of PurchaseCost of InvestmentCurrent ValueReturn %
Hive BlockchainStock 4/16/2020$0.160.2662.50%
Social CapitalStock 5/1/2020$10.2010.63.92%
Fuel Cell EnergyStock 5/3$2.011.98-1.49%
MicrovisionStock 5/18$0.930.985.38%


- The fund sold its stock in IBio as the value of the investment increased over 60%.
- A position has been started in Microvision again at $0.93. A link to the story is here.
- More shares of Fuel Cell Energy have been purchased.



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sunday, May 17, 2020

May 11-15 Performance (Crispr, Fuel Cell, Hive Blockchain, Ibio)

Here are some metrics and some notes for May 11-15.

Metrics


Security/ ProjectType Date of PurchaseCost of InvestmentCurrent ValueReturn %
Hive BlockchainStock 4/16/2020$0.160.2768.75%
Social CapitalStock 5/1/2020$10.2010.523.14%
Fuel Cell EnergyStock 5/3$2.041.84-9.80%
IbioStock 5/11$0.991.4849.49%

Notes

- The fund sold its stake in Crispr. The link to the post explaining why we sold can be found here.

- A new stake in Ibio Pharma was started on Monday. The link explaining its purchase can be found here.  Surprisingly, it is getting to a valuation where a sale might occur.

- Some of the proceeds of the Crispr sale went to purchase more shares of Fuel Cell.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Monday, May 11, 2020

IBIO Stake Started

The fund has started a stock position in biotech firm Ibio Inc.. The company's mission is " developing therapeutics and vaccines for the betterment of human and animal health" and has a patented plant based testing system named Fastpharming. The fund believes Ibio is positioned well during this time of epidemic and has experience with its previous work on SARS. They have connections all around the world and a first class facility in Bryan, Texas. 

Technically, the stock price is leveling at $1.00 with a lot of room to run.  There will likely be a short term move to 2.00 with any positive news and to $300 or above on positive revenue news. We believe this will happen in the next 6 months.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sold Crispr Stake

The fund has sold its stake in Crispr for $60.25. Reasons for the sale are below. We still believe in the valuable work in Crispr. It is more a financial decision than anything else. We will continue to monitor its progress.

- Crispr hit a target of $60.00 far quicker than the fund believed could happen.
- Other opportunities within the biosciences sector have been found.



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sunday, May 10, 2020

May 4-8 Performance (Crispr, Microvision, Hive Blockchain, Social Capital, Fuel Cell Energy)

Here are some metrics and notes for the week of May 4-8.


Security/ProjectType Date of PurchaseCost of InvestmentCurrent ValueReturn %
Crispr TherapeuticsStock 3/23/2020$38.7853.8138.76%
Hive BlockchainStock 4/16/2020$0.160.33106.25%
Social CapitalStock 5/1/2020$10.2010.341.37%
Fuel Cell EnergyStock 5/3$1.932.18.81%

- Sold position in Microvision. Story link here.
- Started position in Fuel Cell Energy. Story link here.
- Bitcoin is back around $10,000 with halving coming up later this month (affecting Hive Blockchain position). 



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.


Tuesday, May 5, 2020

Purchased Shares of Fuel Cell

The fund has purchased shares of Fuel Cell Energy. We purchased the shares for $1.93. We do not have a plan to sell the shares.

Fuel Cell Energy has a mission of  "Delivering clean innovative solutions for the global supply, recovery and storage of energy.".

We are excited to own shares of this company as it is providing an innovative, tested, valuable process that can help with climate change.  We believe the new management is starting to execute on its plans. They have strong partners both domestically, and internationally. The market is wide open with opportunity. 




**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
 

Friday, May 1, 2020

New Position in Social Capital

A new position has been started in Social Capital (symbol IPOB.U). The fund paid $10.20 for each unit. There is no plan to sell the stake and a strong motivation to keep adding to the position.

Social Capital's mission is "to advance humanity by solving the world’s hardest problems". Who doesn't like that mission ;)? In some seriousness, they are a driven company with an exceptional CEO (Samath Palihapitiya). The market value of the companies they invest in have yet to be quantified. KDK Fund expects this stake to keep producing positive results (financial and otherwise) for decades to come.  Their website can be found here.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

1/2 Position in Microvision Sold


The fund has sold 1/2 of its position in Microvision. Some of the reasons are below.

- The price of Microvision rose to $0.40.
- Selling 1/2 the position protects capital, leaving the rest as profit
- There are other opportunities for the capital



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Friday, April 17, 2020

Hive Blockchain Added to Portfolio

Hive Blockchain shares have been added to the portfolio.We currently feel that with the current resources available, this is the right move to be in the blockchain space. Hive Blockchain has the management experience, the existence in a growing market, and access to resources needed to build wealth for its stakeholders. The plan is to hold and likely add shares to the portfolio going forward. 

From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate transactions on blockchain networks — like Ethereum — for rewards paid in cryptocurrencies. Everyday HIVE earns new crypto coins which it can monetize for revenue and cash flow. HIVE offers shareholders exposure to the operating margins from cryptocurrency mining plus a growing portfolio of coins.


KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's existence. The portfolio also has an equity stake in Crispr Therapeutics (post here), and Microvision (post here).  


 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sunday, September 29, 2019

Coming Changes to Investment Banks

by Michael Keane

A few things happened in the last couple of weeks in the IPO arena that strengthens the desire to having  decentralized value more prominent. The not so wonderful feelings of fear and greed were (and are) currently present in the WeWork, Peloton, and Saudi Aramco IPO process and it hurt all three companies.

The closely guarded and deeply centralized IPO process did not work well. Conversations in the media like Sonali Basak from Bloomberg are picking up on this topic. First, the IPO of We Work was pulled with the drama of its financials and the CEO. The IPO of Peloton fell flat on its face. Some feel it got taken on the idea that the valuation is for a tech company. The government of Saudi Arabia is doing more than a few things not in its normal behavior in order to get the IPO of Saudi Aramco done. They seem to be rushing through to the IPO, ignoring the security issues as well as the stagnation and possible downward momentum in the price of oil.

One improvement may be the idea of the Dutch auction model that Google used. It just seems that there is a better deal out there for investors when it comes to IPO's. Firms not associated with the company going public like Morningstar and other analyst firms can and likely should be the driver behind how an IPO should be analyzed and sized up for investors. 

Possible investors in all three companies would be served better in its goals of investment with a more visible and transparent IPO process. Sometimes, it can be a bad combination when you have private company investors looking to profit from their investment by having an IPO and investment bankers hungry for that fee. Taken separately, both are fine. But together, the above mentioned issues show up on a regular basis. If a less biased look at the company can happen, new investors, the company, and the market will be better served.

Good luck in all your trading and investing matters! 


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Sunday, December 16, 2018

Pay Your Price, Not Someone Else's

One of the most important parts of setting up a trade is paying your price for the trade. There are times where the price is right there for the taking right away. Other times, you have to be patient and the price shows up later. But sometimes, the price never shows up. The reaction to the third case will be a great indicator of a trader/investor's level of discipline on trade entry.

Disciplined traders will look at a trade price as not to their liking and walk away ready to find the next trade. They know that the market has a plethora of trade opportunities. Those with faith who continue to improve their learning and execution abilities find moving on from not being able to enter a trade very easy, knowing the next one is right around the corner.

The undisciplined trader will compromise and sacrifice in order to make the trade. They feel a need to make the trade work, even if it means less profit. Those with fear of the market, react more often and do not participate in the market's revenue generating process as well. Generally, ego driven trading will drive the trader investor to make the trade anyway.


Remember that sticking to the calculated entry price is more of a reflection of the trader and their plan than the actual success probability of the trade at that entry price. Letting go of trades that don't go your way should be a regular occurrence. That is ok. Continue to implement your plan. Continue to search for improvements and test those adjustments to verify that they improve your plan.
Faith in the market and one's abilities to learn as they trade are important factors that drive these decisions.

PS - Today's market should provide plenty of opportunity regardless of which side you trade.  Happy trading!

Sunday, June 3, 2018

Ford Dividend Received

A dividend was received by Ford. Portions of the dividend have been used for charity, payments to investors, and back into the account.

Dividend reinvestment is very important to KDK Fund. Over 15% of the dividend received was from reinvesting previous dividends.


Don’t forget to like us on Facebook, Twitter, and Stocktwits! 
 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.


Thursday, December 7, 2017

Why Equities and Bonds are Rising

By Michael Keane


Recently, both equities and stocks have gone up. This is not normally the case. But realistically, this is not a normal market. Both the S&P (up over 17%) and the bond ETF TLT (up over 8%) are up for the year. We believe the main two culprits are new money being invested during a time that the Fed has yet to unwind its bond portfolio.

The main reason we are leaning toward is the thought that we are now seeing an effect of how propped up the bond market is by the Fed, which is worrying. With the tax bill debt increase, along with the Fed planning to unwind a portion of their bond portfolio, bond ETF’s like TLT could be in real danger of not just a decrease in price, but an actual crash. 

New money is also being invested and it is being done so in an allocation method. Putting that on top of the Fed purchases, bonds are probably higher than they should be. 

Per disclosure, our partner KDK Options has had, but does not currently have any positions of either SPY or TLT. 

Don’t forget to like us on Facebook, Twitter, and Stocktwits! 

 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Friday, September 15, 2017

Dividend From Ford Received

A dividend from Ford was received last week. Portions go to charity, investors, and back into the fund for reinvestment. Dividends from previous reinvestments amounted to over 5% of today's receipt.

Dividend reinvestment is an integral part of KDK Fund's wealth building process. It magnifies the compounding each and every quarter.

 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Tuesday, July 25, 2017

New Shares of Ford Purchased

Last week, more shares of Ford were purchased by the fund. This was due partly because of capital increases through KeaneVCC and KDK Options. The price of the purchase was $11.83 before fees and commissions. The purchase adds to the dividend amount received by the fund each quarter. The higher dividend also means more frequent assistance to KeaneVCC's charities.

There is no plan to sell the shares.

**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Friday, June 30, 2017

New Shares of Ford Purchased

A purchase of Ford shares has been made by the fund. The cost of the shares were $11.15 before commissions and fees.There is no time frame or price target for the shares. The expectation is that these shares will held for a very long time. We expect to reinvest dividends in order to compound future dividends.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Sunday, March 26, 2017

Week In Review (Ford Shares Purchase)

Ford was busy this week.

It announced an earnings warning (Bloomberg link here). The drop in the share price allowed KDK Fund to purchase more shares (link here).


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.



Thursday, March 23, 2017

More Shares of Ford Purchased

Because of adding capital and some successful recent trades from KDK Options (USO trade here and FXY trade here), KDK Fund has purchased more shares of Ford. The cost per share was $11.63 before commissions and fees. There is no price or time frame to sell.

The dividend will increase 25% from last quarter's regular $0.15 dividend. Because of reinvestment of dividends, the increase will be higher. The total quarterly dividend for the fund will increase 20%. Reinvested dividends account for 4% of the total owned shares of Ford.

KDK Fund is very excited to continue to build wealth and provide needed assistance to important charitable ventures like Shriner's Hospital in Chicago.

  **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Wednesday, March 8, 2017

Ford Dividend Received

A dividend was received by Ford. The payout was received and broken down into charity, investor payments, and reinvestment.

The dividend was 69% higher than the December payment due to a new purchase of shares from new capital (30% more shares), a hike in the dividend (from $0.15 to $0.20), and the effect of dividends from previously reinvested dividends (now over 5% of shares owned).

This is one stream that KDK Fund expects to continue to grow.

 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.

Sunday, February 5, 2017

AT&T Dividend Received

A dividend from AT&T was received. The dividend was over 3% higher than last quarter and 7% higher than normal because of portions of previous dividends being reinvested along with an annual increase of $0.01 per share. This type of increase is how wealth is created and sustained.

Dividend reinvestment is one way KDK Fund uses to create wealth. Getting 3% quarterly increases due to dividend reinvestment is awesome! Needless to say, a portion of the dividend will be reinvested. More importantly, a portion will be going to charity, which is even better!


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog or to kdkfund@gmail.com or on twitter @kdkfund.